{"id":4884,"date":"2024-06-26T11:53:03","date_gmt":"2024-06-26T11:53:03","guid":{"rendered":"https:\/\/regensight.com\/?p=4884"},"modified":"2024-06-26T11:53:05","modified_gmt":"2024-06-26T11:53:05","slug":"regensight-at-escrs-2024","status":"publish","type":"post","link":"https:\/\/regensight.com\/en\/regensight-at-escrs-2024\/","title":{"rendered":"Regensight at ESCRS 2024"},"content":{"rendered":"<p><strong>Regensight<\/strong> will join the most important and awaited International Annual Conference in corneal and cataract surgery organized by<strong> ESCRS<\/strong> in Barcelona (<a href=\"https:\/\/congress.escrs.org\/\">https:\/\/congress.escrs.org\/<\/a>) on 6-10 September 2024.<\/p>\n<p>With validation of theranostics in the randomized multicenter clinical trial ARGO, Regensight is introducing a revolutionary paradigm shift in Ophthalmology for management of <strong>keratoconus<\/strong>.<\/p>\n<p>At ESCRS 2024, you will learn about <strong>theranostics<\/strong>, combining molecular imaging diagnostics and UV-A light triggered therapeutics, allowing for <strong>predictive, personalized and precise treatment of keratoconus<\/strong> offering predictable outcomes to patients with 91% accuracy and 95% precision.<\/p>\n<p>Stay tuned for our latest news and follow us on linkedin <a href=\"https:\/\/www.linkedin.com\/company\/regensight\/\">https:\/\/www.linkedin.com\/company\/regensight\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regensight will join the most important and awaited International Annual Conference in corneal and cataract surgery organized by ESCRS in Barcelona (https:\/\/congress.escrs.org\/) on 6-10 September 2024. With validation of theranostics in the randomized multicenter clinical trial ARGO, Regensight is introducing a revolutionary paradigm shift in Ophthalmology for management of keratoconus. At ESCRS 2024, you will [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4880,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":""},"categories":[35],"tags":[72,70,44],"_links":{"self":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4884"}],"collection":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/comments?post=4884"}],"version-history":[{"count":2,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4884\/revisions"}],"predecessor-version":[{"id":4887,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4884\/revisions\/4887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media\/4880"}],"wp:attachment":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media?parent=4884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/categories?post=4884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/tags?post=4884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}